used an EZH2 inhibitor to enhance GD2 expression on the surface of Ewing sarcoma cells and significantly inhibited tumor progression when combined with GD2-CAR-T cells for the treatment of Ewing sarcoma (57). The gene discussed is EZH2; the disease is Ewing sarcoma.